PortfoliosLab logo
PortfoliosLab logo
Tools
Performance Analysis
Portfolio Analysis
Factor Model
Portfolios
Lazy PortfoliosUser Portfolios
Discussions
ADMA vs. AMSC
Performance
Risk-Adjusted Performance
Dividends
Drawdowns
Volatility
Financials

Correlation

The correlation between ADMA and AMSC is 0.21, which is considered to be low. This implies their price changes are not closely related. A low correlation is generally favorable for portfolio diversification, as it helps to reduce overall risk by spreading it across multiple assets with different performance patterns.


-0.50.00.51.00.2

Performance

ADMA vs. AMSC - Performance Comparison

The chart below illustrates the hypothetical performance of a $10,000 investment in ADMA Biologics, Inc. (ADMA) and American Superconductor Corporation (AMSC). The values are adjusted to include any dividend payments, if applicable.

0.00%50.00%100.00%150.00%SeptemberOctoberNovemberDecember2025
88.89%
15.22%
ADMA
AMSC

Key characteristics

Sharpe Ratio

ADMA:

3.07

AMSC:

1.17

Sortino Ratio

ADMA:

3.92

AMSC:

1.97

Omega Ratio

ADMA:

1.53

AMSC:

1.23

Calmar Ratio

ADMA:

3.43

AMSC:

0.97

Martin Ratio

ADMA:

17.75

AMSC:

4.45

Ulcer Index

ADMA:

11.37%

AMSC:

21.46%

Daily Std Dev

ADMA:

65.81%

AMSC:

79.67%

Max Drawdown

ADMA:

-91.28%

AMSC:

-99.57%

Current Drawdown

ADMA:

-28.60%

AMSC:

-96.21%

Fundamentals

Market Cap

ADMA:

$3.82B

AMSC:

$1.08B

EPS

ADMA:

$0.27

AMSC:

-$0.03

PEG Ratio

ADMA:

0.00

AMSC:

-0.06

Total Revenue (TTM)

ADMA:

$308.91M

AMSC:

$136.79M

Gross Profit (TTM)

ADMA:

$155.89M

AMSC:

$38.27M

EBITDA (TTM)

ADMA:

$107.80M

AMSC:

$6.36M

Returns By Period

In the year-to-date period, ADMA achieves a -5.83% return, which is significantly lower than AMSC's 6.66% return. Over the past 10 years, ADMA has underperformed AMSC with an annualized return of 3.95%, while AMSC has yielded a comparatively higher 13.83% annualized return.


ADMA

YTD

-5.83%

1M

-12.42%

6M

38.15%

1Y

208.80%

5Y*

32.65%

10Y*

3.95%

AMSC

YTD

6.66%

1M

-8.40%

6M

22.64%

1Y

135.18%

5Y*

33.20%

10Y*

13.83%

*Annualized

Compare stocks, funds, or ETFs

Search for stocks, ETFs, and funds for a quick comparison or use the comparison tool for more options.


Risk-Adjusted Performance

ADMA vs. AMSC — Risk-Adjusted Performance Rank

Compare risk-adjusted metric ranks to identify better-performing investments over the past 12 months.

ADMA
The Risk-Adjusted Performance Rank of ADMA is 9696
Overall Rank
The Sharpe Ratio Rank of ADMA is 9898
Sharpe Ratio Rank
The Sortino Ratio Rank of ADMA is 9696
Sortino Ratio Rank
The Omega Ratio Rank of ADMA is 9595
Omega Ratio Rank
The Calmar Ratio Rank of ADMA is 9696
Calmar Ratio Rank
The Martin Ratio Rank of ADMA is 9797
Martin Ratio Rank

AMSC
The Risk-Adjusted Performance Rank of AMSC is 8080
Overall Rank
The Sharpe Ratio Rank of AMSC is 8282
Sharpe Ratio Rank
The Sortino Ratio Rank of AMSC is 8080
Sortino Ratio Rank
The Omega Ratio Rank of AMSC is 7676
Omega Ratio Rank
The Calmar Ratio Rank of AMSC is 7979
Calmar Ratio Rank
The Martin Ratio Rank of AMSC is 8080
Martin Ratio Rank
The risk-adjusted ranks indicate the investment's position relative to the market. A rank closer to 100 signifies top-performing investments, while a rank closer to 0 might suggest underperformance, based on the selected ratio. The values are calculated based on the past 12 months of returns.

ADMA vs. AMSC - Risk-Adjusted Performance Comparison

This table presents a comparison of risk-adjusted performance metrics for ADMA Biologics, Inc. (ADMA) and American Superconductor Corporation (AMSC). Risk-adjusted metrics are performance indicators that assess an investment's returns in relation to its risk, enabling a more accurate comparison of different investment options.


Sharpe ratio
The chart of Sharpe ratio for ADMA, currently valued at 3.07, compared to the broader market-2.000.002.003.071.17
The chart of Sortino ratio for ADMA, currently valued at 3.92, compared to the broader market-4.00-2.000.002.004.003.921.97
The chart of Omega ratio for ADMA, currently valued at 1.53, compared to the broader market0.501.001.502.001.531.23
The chart of Calmar ratio for ADMA, currently valued at 3.43, compared to the broader market0.002.004.006.003.431.45
The chart of Martin ratio for ADMA, currently valued at 17.75, compared to the broader market0.0010.0020.0017.754.45
ADMA
AMSC

The current ADMA Sharpe Ratio is 3.07, which is higher than the AMSC Sharpe Ratio of 1.17. The chart below compares the historical Sharpe Ratios of ADMA and AMSC, offering insights into how both investments have performed under varying market conditions. These values are calculated using daily returns over the previous 12 months.


Rolling 12-month Sharpe Ratio2.004.006.008.00SeptemberOctoberNovemberDecember2025
3.07
1.17
ADMA
AMSC

Dividends

ADMA vs. AMSC - Dividend Comparison

Neither ADMA nor AMSC has paid dividends to shareholders.


Tickers have no history of dividend payments

Drawdowns

ADMA vs. AMSC - Drawdown Comparison

The maximum ADMA drawdown since its inception was -91.28%, smaller than the maximum AMSC drawdown of -99.57%. Use the drawdown chart below to compare losses from any high point for ADMA and AMSC. For additional features, visit the drawdowns tool.


-40.00%-30.00%-20.00%-10.00%0.00%SeptemberOctoberNovemberDecember2025
-28.60%
-28.63%
ADMA
AMSC

Volatility

ADMA vs. AMSC - Volatility Comparison

The current volatility for ADMA Biologics, Inc. (ADMA) is 16.05%, while American Superconductor Corporation (AMSC) has a volatility of 20.93%. This indicates that ADMA experiences smaller price fluctuations and is considered to be less risky than AMSC based on this measure. The chart below showcases a comparison of their rolling one-month volatility.


10.00%15.00%20.00%25.00%30.00%SeptemberOctoberNovemberDecember2025
16.05%
20.93%
ADMA
AMSC

Financials

ADMA vs. AMSC - Financials Comparison

This section allows you to compare key financial metrics between ADMA Biologics, Inc. and American Superconductor Corporation. You can select fields from income statements, balance sheets, and cash flow statements to easily visualize and compare the financial health of both companies.


Quarterly
Annual

Total Revenue: Total amount of money received from sales and other business activities


Values in USD except per share items
PortfoliosLab logo
Performance Analysis
Portfolio AnalysisPortfolio PerformanceStock ComparisonSharpe RatioMartin RatioTreynor RatioSortino RatioOmega RatioCalmar RatioSummers Ratio
Community
Discussions


Disclaimer

The information contained herein does not constitute investment advice and made available for educational purposes only. Prices and returns on equities are listed without consideration of fees, commissions, taxes, penalties, or interest payable due to purchasing, holding, or selling.

Copyright © 2025 PortfoliosLab